Amicus Therapeutics and Dr. James Wilson with the UPenn Gene Therapy Program are awarded Deal of the Year for their collaboration to advance AAV gene therapy research for rare metabolic disorders.
Amicus Therapeutics and Dr. James Wilson with the UPenn Gene Therapy Program are awarded Deal of the Year for their collaboration to advance AAV gene therapy research for rare metabolic disorders.